56 related articles for article (PubMed ID: 16271833)
21. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
[TBL] [Abstract][Full Text] [Related]
22. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
23. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
24. Nitrotyrosylation of Ca2+ channels prevents c-Src kinase regulation of colonic smooth muscle contractility in experimental colitis.
Ross GR; Kang M; Shirwany N; Malykhina AP; Drozd M; Akbarali HI
J Pharmacol Exp Ther; 2007 Sep; 322(3):948-56. PubMed ID: 17551092
[TBL] [Abstract][Full Text] [Related]
25. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis.
Maugeri N; Franchini S; Campana L; Baldini M; Ramirez GA; Sabbadini MG; Rovere-Querini P; Manfredi AA
Autoimmunity; 2012 Dec; 45(8):584-7. PubMed ID: 22928592
[TBL] [Abstract][Full Text] [Related]
26. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
Chen EY; Mazure NM; Cooper JA; Giaccia AJ
Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
[TBL] [Abstract][Full Text] [Related]
29. Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.
Nakanishi K; Toyoda H; Tanaka S; Yamamoto H; Komada Y; Gabazza EC; Hayashi T; Suzuki K; Ido M
Thromb Res; 2010 Dec; 126(6):511-6. PubMed ID: 21055793
[TBL] [Abstract][Full Text] [Related]
30. CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen.
Israels SJ; McMillan-Ward EM
Thromb Haemost; 2005 Feb; 93(2):311-8. PubMed ID: 15711748
[TBL] [Abstract][Full Text] [Related]
31. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
[TBL] [Abstract][Full Text] [Related]
32. Proteomic signature of thrombin-activated platelets after in vivo nitric oxide-donor treatment: coordinated inhibition of signaling (phosphatidylinositol 3-kinase-γ, 14-3-3ζ, and growth factor receptor-bound protein 2) and cytoskeleton protein translocation.
Peña E; Padro T; Molins B; Vilahur G; Badimon L
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2560-9. PubMed ID: 21836071
[TBL] [Abstract][Full Text] [Related]
33. Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation.
Kubota Y; Tanaka T; Ohnishi H; Kitanaka A; Okutani Y; Taminato T; Ishida T; Kamano H
Leukemia; 2004 Jun; 18(6):1127-37. PubMed ID: 15085152
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
[TBL] [Abstract][Full Text] [Related]
35. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3',5'-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells.
Nedachi T; Akahori M; Ariga M; Sakamoto H; Suzuki N; Umesaki K; Hakuno F; Takahashi SI
Endocrinology; 2000 Jul; 141(7):2429-38. PubMed ID: 10875243
[TBL] [Abstract][Full Text] [Related]
38. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
39. Activation of phosphatidylinositol 3-kinase β by the platelet collagen receptors integrin α2β1 and GPVI: The role of Pyk2 and c-Cbl.
Manganaro D; Consonni A; Guidetti GF; Canobbio I; Visconte C; Kim S; Okigaki M; Falasca M; Hirsch E; Kunapuli SP; Torti M
Biochim Biophys Acta; 2015 Aug; 1853(8):1879-88. PubMed ID: 25960397
[TBL] [Abstract][Full Text] [Related]
40. An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ; Maffucci T
Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
